Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bowlby

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Discovery|March 20, 2013
Functional screening of α7 nicotinic receptor ligandsJohn Dunlop, Ravikumar Peri, Georg C Terstappen, et al.
Nature Reviews. Drug Discovery|March 22, 2008
High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiologyJohn Dunlop, Mark Bowlby, Ravikumar Peri, et al.
Behavioural Brain Research|August 2, 2005
Beta estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioningMark Day, Amy Sung, Sheree Logue, et al.
The Journal of Physiology|February 5, 2002
Remodelling inactivation gating of Kv4 channels by KChIP1, a small-molecular-weight calcium-binding proteinEdward J Beck, Mark Bowlby, W Frank An, et al.
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
Ion channel screeningJohn Dunlop, Mark Bowlby, Ravikumar Peri, et al.
Neuroimage|September 26, 2013
Qualification of fMRI as a biomarker for pain in anesthetized rats by comparison with behavioral response in conscious ratsFuqiang Zhao, Mangay Williams, Mark Bowlby, et al.
Biochemical Pharmacology|August 21, 2007
In vitro screening strategies for nicotinic receptor ligandsJohn Dunlop, Renza Roncarati, Brian Jow, et al.
European Journal of Pharmacology|April 8, 2006
The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slicesFeng Liu, Guoming Zhang, Geoffrey Hornby, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2011
Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonistsDahui Zhou, Jonathan L Gross, Jean Y Sze, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's diseaseJ Steven Jacobsen, Chi-Cheng Wu, Jeffrey M Redwine, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Discovery|March 20, 2013
Functional screening of α7 nicotinic receptor ligandsJohn Dunlop, Ravikumar Peri, Georg C Terstappen, et al.
Nature Reviews. Drug Discovery|March 22, 2008
High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiologyJohn Dunlop, Mark Bowlby, Ravikumar Peri, et al.
Behavioural Brain Research|August 2, 2005
Beta estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioningMark Day, Amy Sung, Sheree Logue, et al.
The Journal of Physiology|February 5, 2002
Remodelling inactivation gating of Kv4 channels by KChIP1, a small-molecular-weight calcium-binding proteinEdward J Beck, Mark Bowlby, W Frank An, et al.
Combinatorial Chemistry & High Throughput Screening|August 13, 2008
Ion channel screeningJohn Dunlop, Mark Bowlby, Ravikumar Peri, et al.
Neuroimage|September 26, 2013
Qualification of fMRI as a biomarker for pain in anesthetized rats by comparison with behavioral response in conscious ratsFuqiang Zhao, Mangay Williams, Mark Bowlby, et al.
Biochemical Pharmacology|August 21, 2007
In vitro screening strategies for nicotinic receptor ligandsJohn Dunlop, Renza Roncarati, Brian Jow, et al.
European Journal of Pharmacology|April 8, 2006
The effect of mGlu5 receptor positive allosteric modulators on signaling molecules in brain slicesFeng Liu, Guoming Zhang, Geoffrey Hornby, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2011
Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonistsDahui Zhou, Jonathan L Gross, Jean Y Sze, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2006
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's diseaseJ Steven Jacobsen, Chi-Cheng Wu, Jeffrey M Redwine, et al.
Pageof 2